Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
暂无分享,去创建一个
J. Coselli | S. Lemaire | L. Conklin | Robert W. Thompson | Xinwen Wang | J. Wilks | Xing-li Wang | Shixiang Wen | Taehee Won | S. Carter | Dominic Leonardelli | Gobind Anand
[1] Timothy C Greiner,et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.
[2] R. Nerem,et al. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. , 1998, Circulation research.
[3] T. Sundt,et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. , 2003, The Journal of thoracic and cardiovascular surgery.
[4] W. Roberts,et al. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. , 1970, The American journal of cardiology.
[5] W. Pearce,et al. Size matters: the relationship between MMP-9 expression and aortic diameter. , 1997, Circulation.
[6] J. Scholes,et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. , 1994, Journal of vascular surgery.
[7] M. Leinonen,et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. , 2001, Journal of vascular surgery.
[8] L. Trombley,et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. , 2004, The Journal of thoracic and cardiovascular surgery.
[9] Z. Galis,et al. Expression of Matrix Metalloproteinase-9 in Endothelial Cells Is Differentially Regulated by Shear Stress , 2003, Journal of Biological Chemistry.
[10] M. Thompson,et al. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. , 2000, Journal of vascular surgery.
[11] R. Nerem,et al. Cyclic strain induces an oxidative stress in endothelial cells. , 1997, The American journal of physiology.
[12] C. Ward. Clinical significance of the bicuspid aortic valve , 2000, Heart.
[13] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[14] R. E. Luna,et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. , 1998, Circulation.
[15] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[16] W. Parks,et al. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. , 1996, Journal of vascular surgery.
[17] M. Abbott. Coarctation of the aorta of the adult type , 1928 .
[18] G. Sicard,et al. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. , 1999, Journal of vascular surgery.
[19] S. Shapiro,et al. Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. , 1999, The Biochemical journal.
[20] H. Baumgartner,et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. , 1999, Circulation.
[21] D. Spina,et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. , 2001, Human pathology.
[22] B. Baxter,et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[23] B. Strauss,et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. , 2003, The Journal of thoracic and cardiovascular surgery.
[24] Avrum I. Gotlieb,et al. Wall Tissue Remodeling Regulates Longitudinal Tension in Arteries , 2002, Circulation research.
[25] H. Nagase,et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] S. Nakatani,et al. Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve , 2003, Circulation.
[27] V. McKusick. Association of congenital bicuspid aortic valve and erdheim's cystic medial necrosis. , 1972, Lancet.
[28] Simpson Ca. PURFICATION OF A GENE. , 1964 .
[29] Chad Johnson,et al. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. , 2003, American journal of physiology. Heart and circulatory physiology.
[30] Po-Huang Lee,et al. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. , 2001, Biochemical and biophysical research communications.
[31] B. Baxter,et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. , 2002, Journal of vascular surgery.
[32] K. Bielenberg,et al. Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[33] M. Abbott. Coarctation of the aorta of the adult type: II. A statistical study and historical retrospect of 200 recorded cases with autopsy, of stenosis or obliteration of the descending arch in subjects above the age of two years , 1928 .
[34] R. Mecham,et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.
[35] J. Powell,et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[36] F. Robicsek. Aortic media in bicuspid valve disease. , 2003, The Annals of thoracic surgery.
[37] W. Parks,et al. Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms a , 1996, Annals of the New York Academy of Sciences.
[38] P. Walker,et al. Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm , 2003, Circulation.
[39] P. Delvenne,et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. , 1996, Journal of vascular surgery.
[40] P. Shah,et al. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. , 1997, Circulation.
[41] H. Dietz,et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[42] Robert W. Thompson,et al. Abdominal aortic aneurysms: basic mechanisms and clinical implications. , 2002, Current problems in surgery.